NASDAQ: SGRYSurgery Partners Inc Stock
$24.84-0.66 (-2.59%)
Updated Apr 25, 2024
SGRY Price
$24.84
Fair Value Price
-$0.80
Market Cap
$3.14B
52 Week Low
$22.05
52 Week High
$45.79
P/E
-276x
P/B
1.58x
P/S
1.47x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.74B
Earnings
-$11.90M
Gross Margin
23.6%
Operating Margin
6.59%
Profit Margin
-0.4%
Debt to Equity
1.93
Operating Cash Flow
$294M
Beta
1.85
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SGRY Overview
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SGRY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SGRY ($24.84) is overvalued by 3,222.92% relative to our estimate of its Fair Value price of -$0.80 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SGRY ($24.84) is not significantly undervalued (3,222.92%) relative to our estimate of its Fair Value price of -$0.80 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SGRY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SGRY due diligence checks available for Premium users.
Be the first to know about important SGRY news, forecast changes, insider trades & much more!
SGRY News
Valuation
SGRY fair value
Fair Value of SGRY stock based on Discounted Cash Flow (DCF)
Price
$24.84
Fair Value
-$0.80
Undervalued by
3,222.92%
SGRY ($24.84) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SGRY ($24.84) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SGRY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SGRY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-276x
Industry
-0.78x
Market
40.97x
SGRY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.58x
Industry
4.54x
SGRY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SGRY's financial health
Profit margin
Revenue
$735.4M
Net Income
-$1.0M
Profit Margin
-0.1%
SGRY's Earnings (EBIT) of $180.80M... subscribe to Premium to read more.
Interest Coverage Financials
SGRY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.9B
Liabilities
$3.8B
Debt to equity
1.93
SGRY's short-term assets ($895.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SGRY's long-term liabilities ($3.32B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SGRY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SGRY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$62.6M
Investing
-$58.1M
Financing
-$44.6M
SGRY's operating cash flow ($293.80M)... subscribe to Premium to read more.
Debt Coverage Financials
SGRY vs Medical Care Facility Stocks
Surgery Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.